Matrix metalloproteinases (MMPs) and the related families of disintegrin metalloproteinases (ADAMs) and ADAMs with thrombospondin repeats (ADAMTSs) play a crucial role in the turnover of extracellular matrix (ECM) components and shedding of cell-surface molecules. The proteolytic activity of metalloproteinases is post-translationally regulated by their endogenous inhibitors, known as tissue inhibitors of metalloproteinases (TIMPs). Several MMPs, ADAMTSs and TIMPs have been reported to be endocytosed by the low-density lipoprotein receptor-related protein-1 (LRP-1). Different binding affinities of these proteins for the endocytic receptor correlate with different turnover rates which, together with differences in their mRNA expression, determines their nett extracellular levels.
INTRODUCTION
Extracellular matrix (ECM) turnover is an important feature of several physiological processes, including development, organogenesis, wound healing and tissue remodelling. The matrix metalloproteinases (MMPs) are a major class of proteinases involved in ECM turnover (1) . The related disintegrin metalloproteinases (ADAMs) and ADAMs with thrombospondin motifs (ADAMTSs) are also involved in ECM turnover by processing of cell surface molecules and various ECM components, respectively (2, 3) . Tissue inhibitors of metalloproteinases (TIMPs) are wedge-shaped proteins that regulate the activity of MMPs, ADAMs and ADAMTSs by interacting with the active site cleft of the enzymes and forming a tight complex with a 1:1 stoichiometry (4) . Under physiological conditions, ECM turnover is regulated by the balance between metalloproteinases and TIMPs, and disruption of this balance is associated with pathological conditions characterised by enhanced ECM degradation, such as arthritis, cancer and cardiovascular disorders (5) (6) (7) .
The expression of metalloproteinases and TIMPs can be regulated at different levels, ranging from regulation of their transcription by cytokines and growth factors, to post-transcriptional regulation by RNA interference. In addition, the catalytic activity of several metalloproteinases can be posttranslationally activated by proteolytic removal of their inhibitory pro-domain (4, 8) . Moreover, a major mechanism that regulates the extracellular levels of several MMPs [including MMP-2 (9), MMP-9 (10) and MMP-13 (11, 12) ] ADAMTSs [including ADAMTS-1 (13), ADAMTS-4 (14) and ADAMTS-5 (15)] and TIMPs [including TIMP-1 (16) , TIMP-2 (9), TIMP-3 (17, 18) ] is endocytosis and subsequent lysosomal degradation via the scavenger receptor lowdensity lipoprotein receptor-related protein 1 (LRP-1) (19, 20) . LRP-1 is considered to be a master regulator of ECM turnover, since the affinity of individual metalloproteinases and TIMPs for LRP-1 determines their extracellular half-life and so controls the balance between ECM degradation and deposition. In this study, we used surface plasmon resonance (SPR) to carry out a systematic analysis of the affinity of several MMPs, ADAMs, ADAMTSs, TIMPs and metalloproteinase/TIMP complexes for LRP-1. This allowed us to investigate the hierarchy of LRP-1 ligands within the metalloproteinase activity network.
Among all proteins analysed, we found that TIMP-3 bound to LRP-1 with the highest affinity. Furthermore, TIMP-3 was able to promote scavenging of its target enzymes, with TIMP-3/metalloproteinase complexes having lower K D values for LRP-1 than observed for the enzymes alone. K D values for TIMP-3/metalloproteinase complexes were almost indistinguishable from that of TIMP-3 alone, indicating that the inhibitor can bridge the binding of metalloproteinases to LRP-1. TIMP-1 and TIMP-2 were also able to promote scavenging of their target enzymes, albeit to a lesser extent, indicating that TIMP-mediated scavenging may be a general mechanism by which inhibited metalloproteinases are cleared from the extracellular environment.
EXPERIMENTAL PROCEDURES

Materials and cells culture
HTB94 human chondrosarcoma cells were from American Culture Type Collection (Manassas, VA, USA), and maintained in DMEM with 10 % FCS, 100 U/ml penicillin and 100 U/ml streptomycin at 37 ºC in 5 % CO 2 . were prepared as previously described. The ectodomain of MMP-14 was expressed in E. coli BL21(DE3). Inclusion bodies were isolated and refolded as described by Huang et al. (29) .
Surface Plasmon Resonance analysis
The affinity of various ligands to LRP-1 was evaluated using a BIAcore T200 (GE, Amersham, UK 
Endocytosis of [ 35 S]TIMP-3, [ 35 S]MMP-1 and MMP-1/TIMP-3 complexes
HTB94 cells were plated at a density of 1x10 6 
RESULTS
TIMP-3 bridges the binding of metalloproteinases to LRP-1 in vitro
We have previously shown that TIMP-3 directly binds to LRP-1 using ELISA (30) . In order to understand this interaction in greater detail, we used surface plasmon resonance to determine the affinity of TIMP-3 for LRP-1 immobilised on a BIAcore sensor chip. Receptor-associated protein (RAP), which is a wellestablished LRP-1 ligand (32,33), was used as positive control for binding.
We measured a K D of 0.6 nM (Table 1) , in good agreement with the previous determination of Lee and colleagues, who reported a K D of 1.4 nM for this interaction (34) . The negative control, BSA, did not show any binding at concentrations up to 2 μ M. TIMP-3 bound to LRP-1 with high affinity (K D = 1.68 nM, Table 1 , Figure 1A ). The N-terminal domain of TIMP-3 (N-TIMP-3)
bound to LRP-1 with a K D of 5.65 nM ( Table 1) , confirming that the minimal binding determinants reside in the N-terminal domain of the inhibitor. This is in line our previous finding that N-TIMP-3 is endocytosed by chondrosarcoma cells in an LRP-1-dependent manner with similar kinetics to that of TIMP-3 (30) . TIMP-1 and TIMP-2 also bound to LRP-1, albeit with 18-fold and 16-fold lower affinities respectively ( Table 1) .
MMP-1 is a new LRP-1 ligand -Because MMP-1 undergoes
autocatalysis at room temperature, we used a catalytically inactive form of MMP-1 [MMP-1 (E200A)] to investigate binding of this enzyme to LRP-1. SPR analysis showed that MMP-1 (E200A) bound to LRP-1 with a K D of 34.6 nM ( Table 1 ). The MMP-1 catalytic domain (MMP-1ΔC) showed no binding to LRP-1 even at micromolar concentrations ( Table 1) , indicating that the hemopexin domain is required for binding of MMP-1 to the receptor. This is in agreement with previous studies showing that the hemopexin domain of MMP-9 mediates the majority of MMP-9 interaction with LRP-1 (35) . (Table 1) .
TIMPs facilitate binding of MMP-1 and MMP-13 to LRP-1 in vitro -
SPR quantifies molecular interactions by detecting changes in refractive index
in the aqueous layer close to the sensor chip surface (36) . Binding of large complexes is associated with greater changes in refractive index. Figure 1B shows MMP-1/TIMP-3 complexes induce a higher response than the same concentration of TIMP-3 alone, indicating that under these experimental conditions, MMP-1 and TIMP-3 bind to LRP-1 as a complex. MMP-1ΔC had no detectable affinity for LRP-1 on its own, but when in complex with TIMP-3, a K D of 6.42 nM was detected ( Table 1) , indicating that TIMP-3 is largely responsible for the binding of this complex to LRP-1. Interaction with TIMP-1 and TIMP-2 also increased MMP-1 affinity for LRP-1, by 2-and 4.5-fold respectively. Unlike for TIMP-3, the affinities of the complexes are higher than that for TIMP-1 or TIMP-2 alone ( Table 1 ), suggesting that MMP-1 either contributes to the binding, or that it stabilises a TIMP-1/-2 conformation with increased LRP-1 affinity.
TIMPs were also able to promote binding of other MMPs to LRP-1. To study MMP-13, which undergoes autodegradation at room temperature, we used a catalytically inactive mutant, namely MMP-13 (E204A). This collagenase had a K D value of 25.6 nM for LRP-1 ( Table 1) . Interaction with TIMP-3 increased its affinity for LRP-1 by 7.6-fold, while interaction with TIMP-1 or TIMP-2 increased its affinity by 2.4-and 4.6-fold respectively.
( Table 1 ). The ectodomain of MMP-14 showed no detectable binding to LRP-1 even at micromolar concentrations. Incubation with TIMP-3 facilitated binding with a K D of 2.95 nM, while incubation with TIMP-1 or TIMP-2 did not detectably improve affinity (Table 1) . 3.00 nM) ( Table 1) .
TIMP-3 increases the affinity of ADAMTS-4 and deletion mutants of
ADAMTS-4 had lower affinity for LRP-1 (K D = 77.56 nM) than ADAMTS-5 (K D = 2-8 nM) (Table 1 ). Binding to TIMP-3 improved the K D to 3.3 nM, indicating that TIMP-3 can also mediate ADAMTS-4 scavenging.
TIMP-3 also improved affinity of ADAM10 and ADAM17 for LRP-1 -
Binding of LRP-1 was undetectable for the free form of either ADAM10 or ADAM17, while binding to TIMP-3 improved their affinity markedly, with K D values of 8.67 for ADAM10/TIMP-3 and 6.84 for ADAM17/TIMP-3. This suggests that TIMP-3 can facilitate the binding of these enzymes to LRP-1.
In conclusion, a systematic SPR analysis showed that TIMP-3 binds to LRP-1 with the highest affinity among TIMPs. TIMPs generally increased affinity of the binding of specific collagenases (MMP-1 and -13) to LRP-1, with TIMP-3 mediating this process to the greatest extent.
Complex formation with metalloproteinases does not affect the kinetics of TIMP-3 endocytosis
TIMP-3 is rapidly internalised by various cell types via LRP-1. In conclusion, the internalisation rate of TIMP-3 is not affected by complex formation with metalloproteinases, suggesting that the inhibitor can drive the internalization of TIMP-3/metalloproteinase complexes.
MMP-1 is endocytosed by cells and TIMP-3, but not other TIMPs, increases its endocytosis rate
SPR analysis showed that MMP-1 directly binds to LRP-1 through its hemopexin domain, suggesting that it could be internalised in an LRP-1- Figure 3F ).
In conclusion, we identified MMP-1 as a novel LRP-1 ligand that, similarly to other metalloproteinases, is actively endocytosed and degraded by cells. TIMP-3, but not TIMP-1 or TIMP-2, increased MMP-1 internalisation rate when in complex with the proteinase.
DISCUSSION
Two classes of metalloproteinases, MMPs and ADAMTSs, play a central role in ECM turnover, together with the ADAMs that are majorly involved in ectodomain shedding of cell-surface components. The activity of these enzymes is finely regulated by their endogenous inhibitors, known as TIMPs.
LRP-1 is an endocytic receptor that has been reported to mediate the internalisation and degradation of a number of MMPs, ADAMTSs and TIMPs, thus functioning as a master regulator of ECM turnover (9,10,12,14-16,18).
Levels of these proteins in the ECM can tightly correlate to their affinity for the receptor. For example, TIMP-3, which was reported to bind to LRP-1 with high affinity, is hardly found extracellularly unless its interaction with LRP-1 and subsequent endocytosis are prevented (18, 38) . Investigating affinities for LRP-1 of different metalloproteinases, TIMPs and metalloproteinase/TIMP complexes can provide useful information about turnover of these proteins and potential effects on ECM turnover.
In the current study, we used SPR to analyse in a systematic manner binding to LRP-1 of a number of MMPs, ADAMs, ADAMTSs, TIMPs and metalloproteinase/TIMP complexes. We found that, among these proteins, TIMP-3 bound to LRP-1 with highest affinity. Furthermore, TIMP-3 increases the affinity for LRP-1 of target proteinases that bind to LRP-1 by themselves, such as MMP-1, MMP-13 and ADAMTS-4, but also that of metalloproteinases, including MMP-14, ADAM10 and ADAM17, which have no affinity for the receptor. ADAMTS-5 binds to and is rapidly endocytosed by LRP-1 (37), and we found that the affinity of ADAMTS-5 lacking the Cterminal thrombospondin domain (ADAMTS5-2) for the receptor was similar to that of TIMP-3. After secretion, ADAMTS-5 is extracellularly processed to truncated forms that acquire distinct features from the full-length counterpart (39, 40) , including different LRP-1 affinities and endocytosis rates (14) .
Expression and purification of recombinant full-length ADAMTS-5 is inefficient, so we did not analyse the full-length enzyme in this study. While Alternatively, the proteinase-inhibitor complex may bind with higher affinity than either protein alone. We observed that TIMP-1 and TIMP-2 complexes with both MMP-1 and MMP-13 had ~2-5-fold higher affinity for LRP-1 than any of the four proteins alone. This is in line with what has been reported for the proMMP-2/TIMP-2 complex, which has ~10-fold higher affinity for LRP-1 than either component alone (9) . This may be due to a conformational change induced by proteinase-inhibitor interaction, as is the case with α 2 -macroglobulin, which has low affinity for LRP-1 in its free form, but which undergoes a conformational change upon proteinase binding that increases affinity of the complex for LRP-1. Alternatively, both enzyme and inhibitor may directly participate in LRP-1 binding, each contributing a lysine residue to form the minimal LRP-1 binding unit (32). We consider this the more likely mechanism, as TIMPs are considered to be conformationally stable, with only minor structural rearrangements upon interaction with MMPs.
However, this mode of binding appears to be insufficient to support bridging to LRP-1 in a complex biological environment, as we found that neither TIMP-1 nor TIMP-2 could increase the rate of MMP-1 endocytosis by HTB94 chondrosarcoma cells. Thus, our kinetic data indicate that TIMP-3 bridges MMP binding to LRP-1 though a different mechanism to that of TIMP-1 and TIMP-2, and that only TIMP-3 can promote scavenging of these target enzymes from the extracellular environment.
The observation that TIMP-3/metalloproteinase complexes and free TIMP-3 have similar affinity for LRP-1 to that of TIMP-3 alone suggests that TIMP-3 interacts with LRP-1 through a site distinct from its inhibitory ridge.
Studies of a number of LRP-1 ligands suggest that a pair of basic residues is responsible for binding to acidic pockets on the complement-type repeats (CRs) of the receptor (41, 42) . For example, extensive mutagenesis and crystallography studies indicate that RAP binds to LRP-1 via two lysine residues, K256 and K270, which are located 22 Å apart on the surface of the molecule (32). TIMP-3 contains a cluster of lysine and arginine residues situated on the opposite side to the inhibitory ridge. This basic region mediates binding to sulfated proteoglycans of the extracellular matrix (43) . We previously found that heparin blocks TIMP-3 binding to LRP-1 (30) , suggesting that the heparin-binding and LRP-1-binding sites of TIMP-3 overlap, and supporting the postulate that the metalloproteinase-inhibitory region of TIMP-3 is spatially separated from the LRP-1-binding and overlapping ECM-binding basic region.
There is emerging evidence that metalloproteinases have functions other than proteolytic cleavage, and that these functions are often related to their non-catalytic domains. For example, a non-catalytic C-terminal fragment of MMP-12 has been shown to have antimicrobial activity (44) . ADAMTS-1 and ADAMTS-4 display anti-angiogenic properties through their ability to bind VEGF and sequester it from VEGFR (45, 46) . Fragments of ADAMTS-5 derived from its ancillary domains have been shown to be anti-tumorigenic both in vitro and in vivo (47) . ADAMTS-12 modulates neutrophil apoptosis, likely by interacting with CD36 and CD47 through its thrombospondin domains (48) . Although it has not been explicitly demonstrated, it is likely that at least some of these non-catalytic functions are maintained when metalloproteinases interact with TIMPs. In addition to its role in inhibiting the It is interesting to speculate that competition between different TIMPs for metalloproteinases could lead to diverse biological responses. TIMP-1 and TIMP-2 would serve primarily to inhibit the catalytic activity of the proteinases, but would not facilitate their endocytic clearance. TIMP-3, on the other hand, is uniquely able to address the enzymes to intracellular degradation and therefore regulate both their proteolytic and non-proteolytic functions. We found that TIMP-3 also bridges binding of members of the ADAM and ADAMTS families to LRP-1. The ectodomains of ADAM10 and ADAM17 do not interact with the receptor unless they are in complex with TIMP-3. This may explain why TIMP-3 decreases cell surface levels of ADAM10 (49) .
In conclusion, this work shows that TIMP-3 can promote LRP-1mediated endocytosis of target metalloproteinases by facilitating their binding to LRP-1. As such, TIMP-3 can inhibit both proteolytic-dependent andindependent activities of metalloproteinases in the extracellular environment. 
Figure 3. MMP-1 is internalised by cells and its uptake is increased by formation of a complex with TIMP-3.
A-D HTB94 cells were incubated with 10 nM [ 35 
